Skadden advises life sciences and health care clients on their most complex legal and regulatory issues across multiple disciplines, including Food and Drug Administration (FDA) regulatory counseling and enforcement defense; government and internal investigations; compliance program design and implementation; litigation and dispute resolution; complex corporate transactions; and the acquisition, enforcement and commercialization of intellectual property and technology assets. Companies and investors across the industry rely on the sector-specific insights of our life sciences and health care attorneys, who work as an integrated team and collaborate to help clients realize scientific innovations as they navigate an ever-evolving landscape.

Skadden is consistently ranked as a leading firm for Healthcare in Chambers USA and for Life Sciences by The Legal 500 U.S. We have been recognized among the top firms for FDA Law by U.S. News — Best Lawyers Best Law Firms. In 2022, Skadden was named M&A Firm of the Year and received the award for Impact Deal of the Year from LMG Life Sciences, and was cited as a leading firm for M&A within the life sciences industry in the publication’s rankings. We also received the Healthcare, Pharma & Biotech Deal of the Year (Large Cap) award from The Deal in 2021.